An observational study in Postoperative Delirium (POD) and Abdominal Neoplasms, sponsored by Fatma Cigdem Ozakin. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-10-05.
Sponsored by Fatma Cigdem Ozakin · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 92 studies in Emergence Delirium with a site in Turkey — 28 open to participants now, 32 under way, none of them phase 3. Emergence Delirium · Turkey.
Among the 92 studies in Emergence Delirium with a site in Turkey, this one is the 27th largest by planned enrollment of the 51 observational ones that give a count, is one of 28 that started in 2026, is one of 51 observational ones, reaches primary completion later than 29 of the 31 other live ones, and was the 87th registered.
753 studies on the registry are indexed under Emergence Delirium; 261 are open to participants now.
Browse Emergence Delirium studies →28 of the 92 studies in Emergence Delirium with a site in Turkey are open now. Recruiting first, the newest first:
Ankara City Hospital Bilkent · Sites in Turkey
Ages 60+ · Healthy volunteers
Elazıg Fethi Sekin Sehir Hastanesi · Sites in Turkey
Ages 65–80 · Women only
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital · Sites in Turkey
Ages 65+
Sakarya University · Sites in Turkey
Ages 6–12
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization · Sites in Turkey
Ages 65+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 141 Emergence Delirium studies recruiting now, 78 (55%) set no upper age limit and 43 (30%) stop at 75 or younger; 33 take children under 18; 24 take healthy volunteers.
This study: 65 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
92 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 28 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is below the median of 164 across 278 observational studies indexed under Emergence Delirium.
Median enrollment 80 across the 41 interventional studies, 110 across the 51 observational. Of the 52 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 92 has an industry lead sponsor. The 10 most frequent:
Fatma Cigdem Ozakin is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Fatma Cigdem Ozakin has 1 study filed under Emergence Delirium — fewer than ten, so there is no comparison to draw.
10 of the studies in Emergence Delirium with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07604337seher orbay yasliPre-emptive Local Anesthesia and Emergence Behavior After Pediatric Dental General Anesthesia | 2026-12 |
| NCT07552259TC Erciyes UniversityEffect of Preoperative Fasting Duration on Postoperative Pain and Emergence Agitation in Pediatric Patients Undergoing Urogenital Surgery | 2026-12-10 |
| NCT07800845Konya City HospitalRemifentanil vs Fentanyl in Children 7-12 After Urologic Surgery: Emergence Delirium and Recovery Quality | 2026-12-15 |
| NCT07877285Elazıg Fethi Sekin Sehir HastanesiImmunonutrition and Neuromonitoring for Postoperative Delirium in Gynecologic Oncology | 2027-01-01 |
| NCT07860996Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research HospitalTotal Intravenous Versus Inhalational Anesthesia in Patients Undergoing Hip Fracture Surgery | 2027-03-30 |
Add all 10 to your calendar (.ics) → With an account.
Among the 92 studies in Emergence Delirium with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This prospective observational cohort study aims to investigate the relationship between perioperative endogenous melatonin levels and postoperative delirium in patients aged 65 years or older undergoing elective abdominal cancer surgery. The study will also evaluate serotonin, kynurenine, kynurenic acid, and vitamin B12 as potential biomarkers associated with postoperative delirium.
Participants will undergo routine standardized general anesthesia and thoracic epidural analgesia. Venous blood samples will be obtained preoperatively and on postoperative day 3. In participants who develop delirium, an additional blood sample will be obtained as soon as possible after delirium is detected. Postoperative delirium will be assessed using the Confusion Assessment Method (CAM) on postoperative days 1, 3, and 5. No experimental drug or additional therapeutic intervention will be administered as part of the study.
Postoperative delirium is an acute neurocognitive disorder that occurs frequently in older patients after major surgery. Neuroinflammation, alterations in neurotransmitter metabolism, oxidative stress, and disruption of circadian rhythm have been proposed as contributing mechanisms.
The primary objective of this prospective observational cohort study is to evaluate the relationship between perioperative endogenous melatonin levels and the development of postoperative delirium in patients aged 65 years or older undergoing elective abdominal surgery for malignancy. Secondary objectives include evaluation of serotonin, kynurenine, kynurenic acid, and vitamin B12 levels in relation to postoperative delirium.
Eligible participants will receive the routine standardized anesthesia and analgesia protocol used at the study center, including general anesthesia and thoracic epidural analgesia. No experimental drug or treatment will be administered.
Venous blood samples will be obtained during the preoperative period for measurement of melatonin, serotonin, kynurenine, kynurenic acid, and vitamin B12. These biomarkers will be measured again on postoperative day 3. In participants who develop postoperative delirium, an additional sample will be obtained as soon as possible after delirium is detected.
Intraoperative hemodynamic parameters, vasopressor requirements, cerebral oxygenation measured by near-infrared spectroscopy, depth of anesthesia measured by Bispectral Index, estimated blood loss, blood product transfusion, anesthesia duration, and surgical duration will also be recorded.
Postoperative delirium will be prospectively evaluated using the Confusion Assessment Method on postoperative days 1, 3, and 5. Participants will subsequently be classified as having or not having postoperative delirium, and perioperative biomarker levels and clinical variables will be compared between these groups.
The study population will consist of patients aged 65 years or older who are scheduled for elective abdominal surgery for malignancy at Bakirkoy Dr. Sadi Konuk Research and Training Hospital and who meet the study eligibility criteria and provide written informed consent.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients aged 65 years or older undergoing elective abdominal surgery for malignancy under general anesthesia with thoracic epidural analgesia. All participants will be prospectively followed for postoperative delirium through postoperative day 5. Participants will not be assigned to treatment groups. For analysis, participants will be classified according to whether postoperative delirium develops based on CAM assessments.
Diagnostic Test: Perioperative Biomarker Assessment · Diagnostic Test: Confusion Assessment Method (CAM)
Venous blood samples will be obtained preoperatively and on postoperative day 3 for measurement of melatonin, serotonin, kynurenine, kynurenic acid, and vitamin B12. In participants who develop postoperative delirium, an additional blood sample will be obtained as soon as possible after delirium is detected. Biomarker measurements will not be used to determine clinical treatment.
The Confusion Assessment Method will be used to assess delirium preoperatively and on postoperative days 1, 3, and 5. Postoperative delirium will be considered present if at least one postoperative CAM assessment is positive.
Change in Serum Melatonin Concentration From Preoperative Baseline to Postoperative Day 3 According to Postoperative Delirium Status
Serum melatonin concentration will be measured preoperatively and on postoperative day 3. For each participant, the change in melatonin concentration will be calculated as the postoperative day 3 value minus the preoperative value and reported in pg/mL. Participants will be classified as having postoperative delirium if at least one CAM assessment on postoperative days 1, 3, or 5 is positive. The change in melatonin concentration will be compared between participants with and without postoperative delirium.
Time frame: Preoperative baseline to postoperative day 3; postoperative delirium status assessed through postoperative day 5
Number of Participants With Postoperative Delirium Assessed by the Confusion Assessment Method
Postoperative delirium will be assessed using the Confusion Assessment Method (CAM) on postoperative days 1, 3, and 5. A participant will be classified as having postoperative delirium if any of these postoperative CAM assessments is positive. According to the CAM algorithm, delirium is present when acute onset and fluctuating course and inattention are present together with either disorganized thinking or an altered level of consciousness. The number and percentage of participants with postoperative delirium will be reported.
Time frame: Postoperative day 1 through postoperative day 5
Change in Serum Serotonin Concentration From Preoperative Baseline to Postoperative Day 3 According to Postoperative Delirium Status
Serum serotonin concentration will be measured preoperatively and on postoperative day 3. The change from the preoperative value will be calculated for each participant and compared between participants with and without postoperative delirium.
Time frame: Preoperative baseline to postoperative day 3
Change in Serum Kynurenine Concentration From Preoperative Baseline to Postoperative Day 3 According to Postoperative Delirium Status
Serum kynurenine concentration will be measured preoperatively and on postoperative day 3. The change from the preoperative value will be calculated for each participant and compared between participants with and without postoperative delirium.
Time frame: Preoperative baseline to postoperative day 3
Change in Serum Kynurenic Acid Concentration From Preoperative Baseline to Postoperative Day 3 According to Postoperative Delirium Status
Serum kynurenic acid concentration will be measured preoperatively and on postoperative day 3. The change from the preoperative value will be calculated for each participant and compared between participants with and without postoperative delirium.
Time frame: Preoperative baseline to postoperative day 3
Plan to share: Undecided
Started Sep 2026 (actual). Primary completion is estimated for Sep 2027, 12 months after the start.
Of 180 non-industry observational studies under Emergence Delirium, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 12 months is below that.
Counting every sponsor, half of 180 studies reached it within 21 months; a quarter within 10 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fatma Cigdem Ozakin